Palmal Shreemoyee, Chakraborty Shruti, Ganguly Swagata, Kundu Suman, Dey Jayanta Bikash, Pramanik Kaushik, Pattanayak Arup Kumar
Department of Microbiology, NRS Medical College, Kolkata 700014, West Bengal, India.
Medical Laboratory Technologist, Department of Microbiology, NRS Medical College, Kolkata 700014, West Bengal, India.
ACS Omega. 2023 Feb 10;8(7):6632-6637. doi: 10.1021/acsomega.2c07119. eCollection 2023 Feb 21.
Dengue is a common arthropod-borne life-threatening febrile illness. This disease affects liver functions with an imbalance of liver enzymes followed by other clinical manifestations. The dengue serotypes can cause asymptomatic infection to more severe versions of hemorrhagic fever and dengue shock syndrome in West Bengal and around the globe. The main aim of this study is to establish how different liver enzymes act in identifying markers for dengue prognosis for the early detection of severe dengue fever (DF). The diagnosis of dengue patients was confirmed by enzyme-linked immunosorbent assay, and associated clinical parameters [aspartate transaminase (AST), alanine aminotransferase (ALT), alkaline phosphatase, total bilirubin, total albumin, total protein, packed cell volume, and platelet count] were analyzed. Furthermore, the viral load estimation was also carried out by RT PCR analysis. The majority of these patients had elevated AST and ALT levels; ALT levels were higher than AST levels, which were partially observed in all non-structural protein 1 antigen- and dengue immunoglobulin M antibody-reactive patients. Almost 25% of patients had very low platelet count or thrombocytopenia. Furthermore, the viral load shows a significant association with all the clinical parameters with a -value of <0.0001. All these liver enzymes are significantly correlated with an increased level of T.BIL, ALT, and AST. This study depicts that the intensity of hepatic involvement may play a critical role in the morbidity and mortality of DF patients. As a result, all of these liver parameters can be useful early markers for determining the severity of the disease, allowing for early detection of high-risk cases.
登革热是一种常见的由节肢动物传播的危及生命的发热性疾病。这种疾病会影响肝功能,导致肝酶失衡,随后出现其他临床表现。在西孟加拉邦及全球范围内,登革热血清型可引起无症状感染,也可导致从出血热到登革热休克综合征等更严重的病症。本研究的主要目的是确定不同的肝酶在识别登革热预后标志物以早期检测重症登革热(DF)方面如何发挥作用。通过酶联免疫吸附测定法确诊登革热患者,并分析相关临床参数[天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、碱性磷酸酶、总胆红素、总白蛋白、总蛋白、红细胞压积和血小板计数]。此外,还通过逆转录聚合酶链反应分析进行病毒载量估计。这些患者中的大多数AST和ALT水平升高;ALT水平高于AST水平,在所有非结构蛋白1抗原和登革热免疫球蛋白M抗体反应性患者中部分观察到这种情况。近25%的患者血小板计数极低或存在血小板减少症。此外,病毒载量与所有临床参数均显示出显著相关性,P值<0.0001。所有这些肝酶均与总胆红素(T.BIL)、ALT和AST水平升高显著相关。本研究表明,肝脏受累的程度可能在DF患者的发病率和死亡率中起关键作用。因此,所有这些肝脏参数都可作为确定疾病严重程度的有用早期标志物,有助于早期发现高危病例。